Refine
Has Fulltext
- yes (23)
Is part of the Bibliography
- yes (23)
Year of publication
Document Type
- Journal article (23)
Language
- English (23)
Keywords
- Biologie (5)
- actinomycetes (5)
- sponges (4)
- marine sponge (3)
- marine sponges (3)
- streptomyces (3)
- NRPS (2)
- Streptomyces (2)
- Streptomyces axinellae (2)
- anti-parasitic (2)
- anti-trypanosomal (2)
- arabidopsis thaliana (2)
- bioactivity (2)
- cysteine protease (2)
- dereplication (2)
- genome analysis (2)
- metabolomics (2)
- protease inhibition (2)
- tetromycin (2)
- A-D (1)
- Actinokineospora (1)
- Agrobacterium (1)
- Allorhizobium vitis (1)
- Candidate Phylum Poribacteria (1)
- FISH-CLEM (1)
- Llullaillaco Volcano (1)
- Meeresschwämme (1)
- Micromonospora (1)
- NMR (1)
- NMR fingerprint (1)
- PKS I (1)
- PKS II (1)
- Porifera (1)
- Red sea (1)
- Spheciospongia vagabunda (1)
- Strahlenpilze (1)
- Subtercola vilae (1)
- Ti plasmids (1)
- Vitis vinifera (1)
- Williamsia sp. ARP1 (1)
- actinobacteria (1)
- actinosporins (1)
- adaption (1)
- annotation (1)
- anti-infective (1)
- anti-protease (1)
- anti-trypanosoma (1)
- antioxidant (1)
- aspergillus fumigatus (1)
- assembly (1)
- bacteria (1)
- bacterial community (1)
- biofilms (1)
- biology (1)
- biosynthesis (1)
- bryozoan bugula-neritina (1)
- butenolide (1)
- cathepsin (1)
- cathepsin-L (1)
- cell compartmentation (1)
- co-cultivation (1)
- cold adaptation (1)
- community structure (1)
- contact lens (1)
- cyclic dipeptide (1)
- cytotoxic (1)
- de novo sequenced genomes (1)
- denaturing gradient gel electrophoresis (1)
- diazepinomicin (1)
- discovery (1)
- draft genome (1)
- drug metabolism (1)
- drugs (1)
- fatty acids (1)
- genomic analysis (1)
- genomic databases (1)
- high resolution visualisation (1)
- in-vitro (1)
- induced metabolites (1)
- leaves (1)
- malaria parasites (1)
- marine (1)
- marine Synechococcus strains (1)
- marine bacteria (1)
- mass spectrometry (1)
- medicine (1)
- metabolic profiling (1)
- metabolites (1)
- metagenomics (1)
- microbial communities (1)
- multivariate analysis (1)
- natural products (1)
- next generation sequencing (1)
- nonribosomal peptide synthetase (1)
- phyllosphere (1)
- phylogenetic (1)
- phylogenetic analysis (1)
- phylogenetics (1)
- plakortide E. (1)
- plakortis halichondroides (1)
- plant communities (1)
- polyketide synthase gene (1)
- polyvinyl chloride (1)
- protease inhibitor (1)
- protein domains (1)
- reveals (1)
- rhodesain (1)
- ribosomal RNA (1)
- ribosomal RNA genes (1)
- secondary metabolites (1)
- secondary metabolomics (1)
- sequence analysis (1)
- single cell (1)
- slowly-binding reversible inhibitor (1)
- spacer sequences (1)
- sponge holicolona-simulans (1)
- sponge-associated actinomyetes (1)
- staphilococci (1)
- staurosporine (1)
- symbiotic bacteria (1)
- systematic affiliation (1)
- transcriptional profiling (1)
- trypanosoma brucei (1)
- valinomycin (1)
- vertical transmission (1)
- waxes (1)
- web server (1)
- whole genome sequencing (1)
Institute
- Julius-von-Sachs-Institut für Biowissenschaften (22)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Pharmakologie und Toxikologie (2)
- Augenklinik und Poliklinik (1)
- Center for Computational and Theoretical Biology (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Organische Chemie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
EU-Project number / Contract (GA) number
- 311932 (4)
Four new tetromycin derivatives, tetromycins 1–4 and a previously known one, tetromycin B (5) were isolated from Streptomyces axinellae Pol001T cultivated from the Mediterranean sponge Axinella polypoides. Structures were assigned using extensive 1D and 2D NMR spectroscopy as well as HRESIMS analysis. The compounds were tested for antiparasitic activities against Leishmania major and Trypanosoma brucei, and for protease inhibition against several cysteine proteases such as falcipain, rhodesain, cathepsin L, cathepsin B, and viral proteases SARS-CoV Mpro, and PLpro. The compounds showed antiparasitic activities against T. brucei and time-dependent inhibition of cathepsin L-like proteases with Ki values in the low micromolar range.
Terrestrial actinomycetes are noteworthy producers of a multitude of antibiotics, however the marine representatives are much less studied in this regard. In this study, 90 actinomycetes were isolated from 11 different species of marine sponges that had been collected from offshore Ras Mohamed (Egypt) and from Rovinj (Croatia). Phylogenetic characterization of the isolates based on 16S rRNA gene sequencing supported their assignment to 18 different actinomycete genera representing seven different suborders. Fourteen putatively novel species were identified based on sequence similarity values below 98.2% to other strains in the NCBI database. A putative new genus related to Rubrobacter was isolated on M1 agar that had been amended with sponge extract, thus highlighting the need for innovative cultivation protocols. Testing for anti-infective activities was performed against clinically relevant, Gram-positive (Enterococcus faecalis, Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria, fungi (Candida albicans) and human parasites (Leishmania major, Trypanosoma brucei). Bioactivities against these pathogens were documented for 10 actinomycete isolates. These results show a high diversity of actinomycetes associated with marine sponges as well as highlight their potential to produce anti-infective agents.
Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 μM; staurosporine IC50 5.30 μM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 μM; staurosporine IC50 0.022 μM; butenolide IC50 31.77 μM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.